Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  International Journal of Molecular Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJMM.5.1.33PMID 10601571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylation, gene expression and the chromatin connection in cancer (review)

  1999cited by this paper
• Induction of p53-dependent, insulin-like growth factor-binding protein-3-mediated apoptosis in glioblastoma multiforme cells by a protein kinase Calpha antisense oligonucleotide.

  1999cited by this paper
• Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review.

  1999cited by this paper
• Interactions of High Affinity Insulin-like Growth Factor-binding Proteins with the Type V Transforming Growth Factor-β Receptor in Mink Lung Epithelial Cells*

  1999cited by this paper
• Characterization of Hepatitis B Virus Integrant that Results in Chromosomal Rearrangement

  1998cited by this paper
• The phylogeny of the insulin-like growth factors.

  1998cited by this paper
• Treatment of hepatocellular carcinoma: medical options.

  1998cited by this paper
• Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3.

  1998cited by this paper
• Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo

  1998cited by this paper
• Hepatocellular carcinoma: risk factors and natural history.

  1998cited by this paper
• Regulatory Actions of Insulin-like Growth Factor-binding Proteins.

  1998cited by this paper
• Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation.

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

  1998cited by this paper
• The Type II Transforming Growth Factor (TGF)-β Receptor-interacting Protein TRIP-1 Acts as a Modulator of the TGF-β Response*

  1998cited by this paper
• Genomic structure and chromosomal location of the human TGFβ‐receptor interacting protein‐1 (TRIP‐1) gene to 1p34.1

  1998cited by this paper
• Surgical options for hepatocellular carcinoma: resection and transplantation.

  1998cited by this paper
• Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma.

  1997cited by this paper
• Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.

  1997cited by this paper
• Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.

  1997cited by this paper
• Imprinted genes in liver carcinogenesis

  1997cited by this paper
• Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily.

  1997cited by this paper
• Conservation and Diversity of Eukaryotic Translation Initiation Factor eIF3*

  1997cited by this paper
• The Type V Transforming Growth Factor β Receptor Is the Putative Insulin-like Growth Factor-binding Protein 3 Receptor*

  1997cited by this paper
• Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner*

  1997cited by this paper
• Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism*

  1997cited by this paper
• Function of the Type V Transforming Growth Factor β Receptor in Transforming Growth Factor β-induced Growth Inhibition of Mink Lung Epithelial Cells*

  1997cited by this paper
• Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells.

  1997cited by this paper
• Multicolor Spectral Karyotyping of Human Chromosomes

  1996cited by this paper
• Report of a complex karyotype in recurrent metastatic fibrolamellar hepatocellular carcinoma and a review of hepatocellular carcinoma cytogenetics.

  1996cited by this paper
• A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p

  1996cited by this paper
• Isolation and mapping of a human gene (RPD3L1) that is homologous to RPD3, a transcription factor in Saccharomyces cerevisiae.

  1996cited by this paper
• Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action.

  1995cited by this paper
• A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor

  1995cited by this paper
• Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.

  1995cited by this paper
• Conservation of a maternal-specific methylation signal at the human IGF2R locus.

  1995cited by this paper
• Promoter-specific IGF2 imprinting status and its plasticity during human liver development.

  1995cited by this paper
• Induction of the growth inhibitor IGF-binding protein 3 by p53

  1995cited by this paper
• The ancient regulatory-protein family of WD-repeat proteins

  1994cited by this paper
• A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis

  1994cited by this paper
• Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

  1992cited by this paper
• Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7.

  1992cited by this paper
• Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.

  1991cited by this paper
• The neuropathology of the acquired immune deficiency syndrome (AIDS). A review.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Chromosomes of human hepatoma cell lines

  1982cited by this paper
• Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

  1980cited by this paper
• Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line

  1979cited by this paper

• Mechanism and application of HDAC inhibitors in the treatment of hepatocellular carcinoma

  2025cites this paper
• Effect of valproic acid on extrinsic and intrinsic apoptotic pathways, cell viability and apoptosis in hepatocellular carcinoma PLC/PRF5 cell line.

  2022cites this paper
• Trichostatin A alleviates HBx-induced HCC metastasis in metabolic stress through up-regulating SIRT3 expression

  2021cites this paper
• Hepatic monoamine oxidase B is involved in endogenous geranylgeranoic acid synthesis in mammalian liver cells

  2020cites this paper
• Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer

  2019cites this paper
• Eukaryotic translation initiation factors and cancer

  2017cites this paper
• Insulin-like growth factor-binding protein-3 inhibits IGF-1-induced proliferation of human hepatocellular carcinoma cells by controlling bFGF and PDGF autocrine/paracrine loops.

  2016cites this paper
• Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.

  2014cites this paper
• EIF3i Promotes Colon Oncogenesis by Regulating COX-2 Protein Synthesis and β-Catenin Activation

  2013cites this paper
• IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors

  2012cites this paper
• Gene Expression-Based Chemical Genomics Identifies Potential Therapeutic Drugs in Hepatocellular Carcinoma

  2011cites this paper
• Unraveling insulin-like growth factor binding protein-3 actions in human disease.

  2009cites this paper
• Targeting histone deacetylases for the treatment of disease

  2008cites this paper
• The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells.

  2007cites this paper
• Genetic analysis of human glioblastomas using a genomic microarray system

  2006cites this paper
• Dysregulation of growth factor signaling in human hepatocellular carcinoma

  2006cites this paper
• Epigenetic activation of α4, β2 and β6 integrins involved in cell migration in trichostatin A-treated Hep3B cells

  2005cites this paper
• Epigenetic activation of alpha4, beta2 and beta6 integrins involved in cell migration in trichostatin A-treated Hep3B cells.

  2005cites this paper
• IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.

  2005cites this paper
• Molecular Profiling of Human Hepatocellular Carcinoma Defines Mutually Exclusive Interferon Regulation and Insulin-Like Growth Factor II Overexpression

  2004cites this paper
• Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines.

  2004cites this paper
• Regulatory Mechanism of Insulin-Like Growth Factor Binding Protein-3 in Non-Small Cell Lung Cancer

  2004cites this paper
• Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells.

  2003cites this paper
• The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?

  2003cites this paper
• Susceptibility of multidrug resistance tumor cells to apoptosis induction by histone deacetylase inhibitors

  2003cites this paper
• The Insulin-like Growth Factors and Insulin-signalling Systems: An Appealing Target for Breast Cancer Therapy?

  2003cites this paper
• Differential activation of the IGF binding protein-3 promoter by butyrate in prostate cancer cells.

  2002cites this paper
• Detection of chromosomal imbalances in hepatocellular carcinoma

  2002cites this paper
• Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma.

  2002cites this paper
• Applications of SKY in Cancer Cytogenetics

  2002cites this paper
• Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.

  2002cites this paper
• Untersuchungen zur Bedeutung der IGF-II-Expression humaner Lebertumorzelllinien

  2002cites this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cites this paper
• The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells.

  2002cites this paper
• 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines

  2001cites this paper
• Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo.

  2001cites this paper
• Histone deacetylase as a therapeutic target.

  2001cites this paper
• Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.

  2001cites this paper
• Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer.

  2001cites this paper
• Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis.

  2001cites this paper
• Advances in the detection of chromosomal aberrations using spectral karyotyping

  2001cites this paper
• Trichostatin A-Mediated Regulation of Gene Expression and Protein Kinase Activities: Reprogramming Tumor Cells for Ribotoxic Stress-Induced Apoptosis

  2000influential citation